QSS
GH icon

Quantitative Systematic Strategies’s Guardant Health GH Stock Holding History

Quantitative Systematic Strategies’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-5,963
Closed -$741K – 155
2021
Q2 		$741K Buy
5,963
+1,747
+41% +$235K 0.26% 130
2021
Q1 		$644K Sell
4,216
-10,424
-71% -$1.58M 0.1% 314
2020
Q4 		$1.89M Buy
14,640
+798
+6% +$91.8K 0.27% 113
2020
Q3 		$1.55M Buy
13,842
+2,153
+18% +$197K 0.27% 112
2020
Q2 		$948K Buy
+11,689
New +$942K 0.19% 181
2020
Q1 		– Sell
-13,449
Closed -$1.05M – 362
2019
Q4 		$1.05M Buy
+13,449
New +$969K 0.15% 212

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Quantitative Systematic Strategies's GH Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Guardant Health (GH) in Q3 2021, closing a stake of 5,963 shares — an estimated $741K sold.

Quantitative Systematic Strategies first reported a position in GH in Q4 2019 and held it in 6 quarters. The position peaked at $1.89M in Q4 2020. 373 funds tracked by Wall St. Rank hold GH as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Guardant Health position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 5,963 Guardant Health shares in Q3 2021, an estimated $741K.
  • Quantitative Systematic Strategies first reported a position in Guardant Health in Q4 2019 and held it in 6 quarters.
  • Quantitative Systematic Strategies's Guardant Health position peaked at $1.89M in Q4 2020.
  • 373 funds tracked by Wall St. Rank held Guardant Health as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.